期刊文献+

心房颤动伴缺血性脑卒中患者炎症因子水平变化及他汀类药物抗炎作用的临床研究 被引量:3

The change of inflammatory factors levels of atrial fibrillation patients with ischemic stroke and the anti-inflammatory effects of statins drugs
暂未订购
导出
摘要 目的观察心房颤动伴缺血性脑卒中患者炎症因子水平变化及他汀类药物抗炎作用。方法选择308例患者为研究对象,分为心房颤动组(AF组)及心房颤动伴缺血性脑卒中组(AFIS组),择期测定HsCRP、IL-6、TNF-α。给予阿托伐他汀钙片20 mg每日一次口服,连用两周后再次进行上述指标检测。结果 AFIS组患者炎症因子HsCRP,IL-6,TNF-α水平均明显高于AF组患者,AFIS患者炎症因子水平与病情轻重及梗死面积的大小有关,治疗后患者炎症因子HsCRP,IL-6,TNF-α水平明显降低。结论 AFIS组患者较AF组患者有更高的炎症水平,其炎症因子水平与病情轻重及梗死面积的大小有关,他汀类药物对此治疗有效。 Objective To observe the change of inflammatory factors levels of atrial fibrillation patients with ischemic stroke, and statins" anti - inflammatory effect. Methods 308 patients were divided into atrial fibrillation group ( AF group) and atrial fibrillation associated with ischemic stroke group (AFIS group). HsCRP, IL- 6 and TNF -alpha were detected after two week administration of atorvastatin calcium (Lipitor)20mg once daily orally and continuously. Result The inflammatory factors levels HsCRP, IL - 6 and TNF - α of AFIS patients were in average significantly higher than those of AF group patients. The inflammatory factors levels of AFIS patients were related to the severity and the size of the infarct size. The inflammatory factors levels including HsCRP, IL - 6, TNF - α were significantly reduced after treatment in patients. Conclusion the AFIS group patients have higher levels of inflammation than those of the AF group patients, and their inflammatory factors level were related to the severity and the size of the infarct size. In addition, Statin drugs were effective for this treatment.
出处 《延安大学学报(医学科学版)》 2012年第3期9-11,23,共4页 Journal of Yan'an University:Medical Science Edition
基金 延安大学附属医院研究生创新基金项目 项目编号11YJ15
关键词 心房颤动 缺血性脑卒中 炎症因子 atrial fibrillation ischemic stroke inflammatory factors
  • 相关文献

参考文献9

二级参考文献42

  • 1彭华,郭洪志.急性脑梗死及其并发多脏器功能障碍综合征患者血清C反应蛋白水平的变化[J].临床神经病学杂志,2004,17(5):330-332. 被引量:58
  • 2万晓余,吴淑华.肿瘤坏死因子结构研究进展[J].生物化学与生物物理进展,1993,20(5):351-356. 被引量:6
  • 3各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33100
  • 4脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15809
  • 5Dziedzic T, Gryz EA, Turaj W, et al. Serum interleukin-6 soluble receptor in relation to interleukin-6 in stroke patients [ J]. J Mol Neurosei, 2004,24 : 293.
  • 6Silvcstri A, Vitale C, Ferretti F, et al. Plasma levels of inflammatory C-reactive protein and intcrleukin-6 predict outcome in elderly patients with stroke [ J ]. J Am Geriatr Soc ,2004,52:1586.
  • 7Chan CS, Smieja M, Molloy W, et al. Lack of association between vascular dementia and chlamydia pneumoniae infection : a case-control study[J]. BMC Neurol, 2004,4:15.
  • 8van Der Meer IM, de Maat MP, Hak AE, et al. C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree : the rotterdam study [ J ]. Stroke,2002, 33:2750.
  • 9Hashimoto H, Kitagawa K, Hougaku H, et al. Relationship between C-reactive protein and progression of early carotid atherosclerosis in hypertensive subjects[ J]. Stroke,2004,35:1625.
  • 10Patrick L,Uzick M. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors,alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature[ J]. Altern Med Rev, 2001 , 6:248.

共引文献172

同被引文献24

  • 1吴光哲,郑兴.慢性房颤C反应蛋白、白介素、纤维蛋白原与前血栓状态的关系[J].心血管康复医学杂志,2005,14(5):500-501. 被引量:7
  • 2Heppell RM, Berkin KE,McLenachan JM, et al. Haemostaticand haemodynamic abnormalities associated with left atrialthrombosis in nonrheumatic atrial fibrillation [J]. Heart, 1997,77 (5): 407-411.
  • 3Eckman MH, Rosand J. KundsenKA, et al. Can patients be an-ticoagulated after intracerebral hemorrhage. A decision analysis[J]. Stroke’ 2003’ 34 (7): 1710 -1716.
  • 4Iqbal MB, Taneja AK,Lip GY, et al. Recent developments inatrial fibrillation [J]. BMJ, 2005,330 (7485) : 238- 243.
  • 5Kiechl S. Stroke prevention in atrial fibrillation-transfer of studyresults to the practice [J]. Wien Klin Wochenschr,2004. 116(24): 817-819.
  • 6Nakajima K. The relationship between left atrial thrombus andhematological markers in patients with chronic non-rheumatic at-rial fibrillation [J]. Nihon Ronen Igakkai Zasshi,2000,37(11): 903-907.
  • 7Go AS, Reed GL,Hylek EM, et al. Factor V Leiden and risk ofischemic stroke in nonvalvular atrail fibrillation; the AnTicoagu-lation and Risk Factors in Atrial Fibrillation (ATRIA) Study[Jj. J Thromb Thrombolysis, 2003, 15 (1) : 41 - 46.
  • 8Fang MC, Singer DE,Chang Y,et al. Gender differences in therisk of ischemic stroke and peripheral embolism in atrial fibrilla-tion: the AnTicoagulation and Risk factors In Atrial fibrillation(ATRIA) Study [J]. Circulation, 2005,112 (12): 1687 -1691.
  • 9Tsivgoulis G,Spengos K, Zakopoulos N,et al. Efficacy of anti-coagulation for secondary stroke prevention in older people withnon-valvular atrial fibrillation: a prospective case series study[J], Age Ageing, 2005,34 (1): 35 - 40.
  • 10Asinger RW,Koehler J,Pearce LA, et al. Pathophysiologic cor-relates of thromboembolism in nonvalvular atrial fibrillation: II.Dense spontaneous echocardiographic contrast (The Stroke Pre-vention in Atrial Fibrillation [SPAF-H] study) [J]. J Am SocEchocardiogr, 1999,12 (12) : 1088 -1096.

引证文献3

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部